Cargando…
Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
The aim of this study was to explore the effects of herbal drug pharmacokinetic interactions on the biotransformation of molnupiravir and its metabolite β-D-N4-hydroxycytidine (NHC) in the blood and brain. To investigate the biotransformation mechanism, a carboxylesterase inhibitor, bis(4-nitropheny...
Autores principales: | Chang, Chun-Hao, Peng, Wen-Ya, Lee, Wan-Hsin, Lin, Tung-Yi, Yang, Muh-Hwa, Dalley, Jeffrey W., Tsai, Tung-Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228170/ https://www.ncbi.nlm.nih.gov/pubmed/37302376 http://dx.doi.org/10.1016/j.jpba.2023.115499 |
Ejemplares similares
-
Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier
por: Chang, Chun-Hao, et al.
Publicado: (2023) -
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply
por: Lin, Sunny Jui-Shan, et al.
Publicado: (2022) -
The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
por: Ho, Shung-Tai, et al.
Publicado: (2023) -
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3
por: Tseng, Yu-Hwei, et al.
Publicado: (2022) -
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 2
por: Lee, Ming-Yung, et al.
Publicado: (2022)